Australia is closely watching the arrival of retatrutide, a novel dual GIP and GLP-1 receptor medication , representing a significant advance in addressing excess weight. Early clinical trials have demonstrated https://jakubbjxo808179.blogofoto.com/75359178/new-treatment-in-australia-a-new-breakthrough-for-obesity-management